1-4 of 4
Christopher J Ferreri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma

Rahul Banerjee, Alicia Richards, Shonali Midha, Aimaz Afrough, Faiz Anwer, Djordje Atanackovic, Shebli Atrash, Veronika Bachanova, Amer M. Beitinjaneh, Evguenia Ouchveridze, Omar Castaneda Puglianini, Saurabh Chhabra, Kara I Cicero, James A Davis, Binod Dhakal, Danai Dima, Christopher J Ferreri, Peter A. Forsberg, Ciara L Freeman, Megan M. Herr, Tania Jain, Murali Janakiram, Jack Khouri, Mehmet Hakan Kocoglu, Anupama Deepa Kumar, Yuxin Liu, Frederick L Locke, Joseph P. McGuirk, Lekha Mikkilineni, Omar Nadeem, Ricardo D Parrondo, Oren Pasvolsky, Lauren C Peres, Sneha Purvey, Shahzad Raza, Ran Reshef, Shambavi Richard, Adriana C Rossi, Douglas W Sborov, Leyla Shune, Charlotte B. Wagner, Saurabh S. Zanwar, Surbhi Sidana, Krina K. Patel, Doris K Hansen, Shaji K Kumar, Yi Lin, Thomas G Martin, Peter M Voorhees, Larry D. Anderson, Jr., Andrew J Cowan, Gurbakhash Kaur
Journal: Blood Advances
Blood Adv bloodadvances.2025016131.
https://doi.org/10.1182/bloodadvances.2025016131
Published: 2025
Includes: Supplemental data
Journal Articles

BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement

Mahmoud R. Gaballa, Omar Castaneda Puglianini, Adam Cohen, Dan Vogl, Alfred Chung, Christopher J. Ferreri, Peter Voorhees, Doris K. Hansen, Krina K. Patel
Journal: Blood Advances
Blood Adv (2025) 9 (5): 1171–1180.
https://doi.org/10.1182/bloodadvances.2024014345
Published: 2025
Journal Articles

MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma

Clinical Trials & Observations
Manisha Bhutani, Myra Robinson, David Foureau, Shebli Atrash, Barry Paul, Fei Guo, Jason M. Grayson, Anna Ivanina-Foureau, Mauricio Pineda-Roman, Cindy Varga, Reed Friend, Christopher J. Ferreri, Xhevahire Begic, Sarah Norek, Tiffany Drennan, Michelle B. Anderson, James T. Symanowski, Peter M. Voorhees, Saad Z. Usmani
Journal: Blood Advances
Blood Adv (2025) 9 (3): 507–519.
https://doi.org/10.1182/bloodadvances.2024014417
Published: 2025
Includes: Supplemental data
Journal Articles

Clinical outcomes after idecabtagene vicleucel in older patients with multiple myeloma: a multicenter real-world experience

Nilesh M. Kalariya, Michelle A. T. Hildebrandt, Doris K. Hansen, Surbhi Sidana, Jack Khouri, Christopher J. Ferreri, William N. Doyle, Omar Castaneda-Puglianini, Ciara L. Freeman, Vanna Hovanky, Hitomi Hosoya, Leyla O. Shune, Krina K. Patel
Journal: Blood Advances
Blood Adv (2024) 8 (17): 4679–4688.
https://doi.org/10.1182/bloodadvances.2024013540
Published: 2024
Includes: Supplemental data